C. Chanal

2.3k total citations
47 papers, 2.0k citations indexed

About

C. Chanal is a scholar working on Molecular Medicine, Endocrinology and Molecular Biology. According to data from OpenAlex, C. Chanal has authored 47 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Medicine, 16 papers in Endocrinology and 12 papers in Molecular Biology. Recurrent topics in C. Chanal's work include Antibiotic Resistance in Bacteria (35 papers), Vibrio bacteria research studies (10 papers) and Bacterial biofilms and quorum sensing (10 papers). C. Chanal is often cited by papers focused on Antibiotic Resistance in Bacteria (35 papers), Vibrio bacteria research studies (10 papers) and Bacterial biofilms and quorum sensing (10 papers). C. Chanal collaborates with scholars based in France, Switzerland and Luxembourg. C. Chanal's co-authors include D. Sirot, J. Sirot, Roger Labia, Christophe de Champs, Richard Bonnet, Jorge Luiz Mello Sampaio, Cécile Henquell, R Cluzel, Hélène Marchandin and A Petit and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

C. Chanal

45 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Chanal France 26 1.8k 731 540 426 422 47 2.0k
M. H. Nicolas France 16 2.0k 1.1× 894 1.2× 502 0.9× 497 1.2× 506 1.2× 32 2.4k
Εva Tzelepi Greece 29 2.2k 1.3× 975 1.3× 644 1.2× 526 1.2× 554 1.3× 75 2.6k
Inna Chmelnitsky Israel 25 1.6k 0.9× 703 1.0× 411 0.8× 337 0.8× 357 0.8× 38 1.9k
R. Jungwirth Germany 17 1.1k 0.6× 487 0.7× 430 0.8× 366 0.9× 343 0.8× 25 1.5k
Zeqing Wei China 21 1.6k 0.9× 750 1.0× 497 0.9× 363 0.9× 368 0.9× 32 2.0k
Ellen Smith Moland United States 29 2.3k 1.3× 989 1.4× 464 0.9× 655 1.5× 622 1.5× 52 2.6k
Costas C. Papagiannitsis Czechia 25 1.8k 1.0× 864 1.2× 444 0.8× 387 0.9× 406 1.0× 77 2.0k
Aggeliki Poulou Greece 25 1.6k 0.9× 741 1.0× 348 0.6× 446 1.0× 389 0.9× 36 1.8k
Marie-France I. Palepou United Kingdom 16 1.4k 0.8× 638 0.9× 522 1.0× 411 1.0× 296 0.7× 17 1.8k
Anna Baraniak Poland 25 1.4k 0.8× 741 1.0× 390 0.7× 215 0.5× 369 0.9× 56 1.6k

Countries citing papers authored by C. Chanal

Since Specialization
Citations

This map shows the geographic impact of C. Chanal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Chanal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Chanal more than expected).

Fields of papers citing papers by C. Chanal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Chanal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Chanal. The network helps show where C. Chanal may publish in the future.

Co-authorship network of co-authors of C. Chanal

This figure shows the co-authorship network connecting the top 25 collaborators of C. Chanal. A scholar is included among the top collaborators of C. Chanal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Chanal. C. Chanal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cambonie, Gilles, Lynn Bar‐On, Clémentine Combes, et al.. (2024). Management of neonates exposed prenatally to opioids: Impact of a developmental care program implementation. Early Human Development. 198. 106132–106132.
2.
3.
Mazurier, E., et al.. (2011). Devenir à 5 ans des enfants de mères dépendantes aux opiacés : effets d’un suivi multidisciplinaire pendant la grossesse. Archives de Pédiatrie. 18(11). 1130–1138. 7 indexed citations
4.
Lavigne, Jean‐Philippe, Anne‐Béatrice Blanc‐Potard, Gisèle Bourg, et al.. (2006). Virulence genotype and nematode-killing properties of extra-intestinal Escherichia coli producing CTX-M β-lactamases. Clinical Microbiology and Infection. 12(12). 1199–1206. 55 indexed citations
5.
Robin, Frédéric, Julien Delmas, C. Chanal, et al.. (2005). TEM-109 (CMT-5), a Natural Complex Mutant of TEM-1 β-Lactamase Combining the Amino Acid Substitutions of TEM-6 and TEM-33 (IRT-5). Antimicrobial Agents and Chemotherapy. 49(11). 4443–4447. 26 indexed citations
6.
Champs, Christophe de, et al.. (2004). Frequency and diversity of Class A extended-spectrum β-lactamases in hospitals of the Auvergne, France: a 2 year prospective study. Journal of Antimicrobial Chemotherapy. 54(3). 634–639. 53 indexed citations
7.
Champs, Christophe de, et al.. (2004). Factors associated with antimicrobial resistance among clinical isolates of Klebsiella pneumoniae : 1-year survey in a French university hospital. European Journal of Clinical Microbiology & Infectious Diseases. 23(6). 456–462. 19 indexed citations
8.
Marchandin, Hélène, Sylvain Godreuil, H. Darbas, et al.. (2003). Extended-Spectrum β-Lactamase TEM-24 in an Aeromonas Clinical Strain: Acquisition from the Prevalent Enterobacter aerogenes Clone inFrance. Antimicrobial Agents and Chemotherapy. 47(12). 3994–3995. 33 indexed citations
9.
Champs, Christophe de, Richard Bonnet, D. Sirot, C. Chanal, & J. Sirot. (2000). Clinical relevance of Proteus mirabilis in hospital patients: a two year survey. Journal of Antimicrobial Chemotherapy. 45(4). 537–539. 57 indexed citations
10.
Bonnet, Richard, Jorge Luiz Mello Sampaio, C. Chanal, et al.. (2000). A Novel Class A Extended-Spectrum β-Lactamase (BES-1) in Serratia marcescens Isolated in Brazil. Antimicrobial Agents and Chemotherapy. 44(11). 3061–3068. 82 indexed citations
11.
Chanal, C., et al.. (1996). Survey of prevalence of extended spectrum β-lactamases among Enterobacteriaceae. Journal of Antimicrobial Chemotherapy. 38(1). 127–132. 51 indexed citations
12.
Lemozy, J, D. Sirot, C. Chanal, et al.. (1995). First characterization of inhibitor-resistant TEM (IRT) beta-lactamases in Klebsiella pneumoniae strains. Antimicrobial Agents and Chemotherapy. 39(11). 2580–2582. 52 indexed citations
13.
Henquell, Cécile, et al.. (1994). Frequency of inhibitor-resistant TEM β-lactamases in Escherichia coli isolates from urinary tract infections in Fran. Journal of Antimicrobial Chemotherapy. 34(5). 707–714. 60 indexed citations
14.
Sirot, D., C. Chanal, Cécile Henquell, et al.. (1994). Clinical isolates of Escherichia coli producing multiple TEM mutants resistant to β-lactamase inhibitors. Journal of Antimicrobial Chemotherapy. 33(6). 1117–1126. 34 indexed citations
15.
Labia, Roger, et al.. (1989). Interactions of meropenera, with  -lactamases, including enzymes with extended-spectrum activity against third-generation cephalosporins. Journal of Antimicrobial Chemotherapy. 24(suppl A). 219–223. 18 indexed citations
16.
Champs, Christophe de, et al.. (1989). Prospective survey of colonization and infection caused by expanded-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae in an intensive care unit. Journal of Clinical Microbiology. 27(12). 2887–2890. 110 indexed citations
17.
Chanal, C., D. Sirot, Marie Chanal, et al.. (1989). Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum  -lactamases. Journal of Antimicrobial Chemotherapy. 24(suppl A). 133–141. 24 indexed citations
18.
Sirot, Danielle, C. Chanal, J. Sirot, & Roger Labia. (1989). Susceptibility of new β-lactams to the expanded-spectrum β-lactamase CTX-1. Infection. 17(1). 28–30. 14 indexed citations
19.
Sirot, D., C. Chanal, Roger Labia, et al.. (1989). Comparative study of five plasmid-mediated ceftazidimases isolated in Klebsiella pneumoniae. Journal of Antimicrobial Chemotherapy. 24(4). 509–521. 25 indexed citations
20.
Sirot, J., C. Chanal, A Petit, et al.. (1988). Klebsiella pneumoniae and Other Enterobacteriaceae Producing Novel Plasmid-Mediated  -Lactamases Markedly Active Against Third-Generation Cephalosporins: Epidemiologic Studies. Clinical Infectious Diseases. 10(4). 850–859. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. H. Nicolas Breakdown of academic impact, for papers by Εva Tzelepi Breakdown of academic impact, for papers by Inna Chmelnitsky Breakdown of academic impact, for papers by R. Jungwirth Breakdown of academic impact, for papers by Zeqing Wei Breakdown of academic impact, for papers by Ellen Smith Moland Breakdown of academic impact, for papers by Costas C. Papagiannitsis Breakdown of academic impact, for papers by Aggeliki Poulou Breakdown of academic impact, for papers by Marie-France I. Palepou Breakdown of academic impact, for papers by Anna Baraniak
Rankless by CCL
2026